RQM+ buys medtech software platform Giotto Compliance
RQM+, a Monroeville, PA-based firm specializing in regulatory, quality, and compliance consulting for medical device and diagnostics manufacturers, has acquired Giotto Compliance, an AI-powered reporting platform.
Giotto Compliance provides an AI platform to boost efficiency and effectiveness of regulatory reports and filings across the product lifecycle for medical devices and in vitro diagnostics. The product streamlines workflows to deliver audit-ready reports – saving more than 30 hours per clinical evaluation report, according to Giotto’s website.
Prior to its acquisition by RGM+, Giotto Compliance was part of Giotto.ai, a Lausanne, Switzerland-based startup focusing on AI-based software. Giotto Compliance has 26 employees listed on LinkedIn.
“We have only begun to scratch the surface of what can be achieved by integrating Giotto Compliance AI technology throughout our consulting, clinical trials, laboratory and reimbursement services,” said Margaret Keegan, CEO of RQM+. “We are fortunate to have our Chief Digital and Technology Officer Alaric Jackson lead this new business unit. He will expand the capabilities of Giotto Compliance to enhance our current services as well as offer a standalone solution that can be leveraged to streamline regulatory document development while maintaining compliance with global regulations.”
Jackson, who joined RQM+ in July, brings more than 20 years of technology leadership experience in pharma and contract research organizations. He previously served as VP and head of global medical, regulatory, and quality technology at GlaxoSmithKline.
“Currently, Giotto Compliance reduces the burden of data collection, analysis, and creation of regulatory documentation, such as clinical evaluation reports, allowing our team to focus on creative solutions, complex problem solving and impactful work,” Jackson said. “We will accelerate the creation of AI models and functionality to expand its capabilities across a wide range of processes for MedTech manufacturers, regulators, and service providers.”
Formed from the 2020 merger of R&Q and Maetrics, RQM+ is the largest medical device and diagnostics-focused full-service regulatory and quality consulting firm in the world. The firm delivers services in regulatory strategy and submissions, quality systems advisory, safety risk management, implementation of compliance programs (including for the EU), program management with a quality assurance focus, and regulatory finding response management.
RQM+ has more than 500 people across offices in the US, UK, and Switzerland. It is a portfolio company of Linden Capital Partners, which acquired it in 2021.
